ArticleOncotarget2017

Pharmacometabolomics identifies dodecanamide and leukotriene B4 dimethylamide as a predictor of chemosensitivity for patients with acute myeloid leukemia treated with cytarabine and anthracycline.

Guangguo Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.